Dali Yan
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, MicroRNA in disease regulation, RNA modifications and cancer, Circular RNAs in diseases, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner(2017)239 cited
- → MiR-138: A promising therapeutic target for cancer(2017)104 cited
- → MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer(2016)67 cited
- → Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin(2017)30 cited
- → Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials(2017)29 cited
- → Liver X receptor as a drug target for the treatment of breast cancer(2016)25 cited
- → Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray(2016)20 cited
- → Chimaeric antigen receptor T-cell therapy for tumour immunotherapy(2017)20 cited
- → Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer(2017)19 cited
- → Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation(2017)18 cited